Serac Healthcare Partners with University of Oxford to Evaluate the Potential of ⁹⁹ᵐTc-Maraciclatide to Diagnose Endometriosis Non-Invasively

  • Designer
  • June 7, 2022
  • Edited 4 months ago

Serac Healthcare Ltd is working with the University of Oxford to investigate whether an experimental image marker (⁹⁹ᵐTc-maraciclatide) that binds to areas of inflammation can be used to visualise endometriosis using a 20-minute scan.

Read more
Share this article with a friend

Get in Touch

Reach out to us via email
info@seraclifesciences.com

Connect with Us

Follow us on social media
Follow us on LinkedIn

Serac Life Sciences Ltd is a limited company registered in England and Wales. Serac Healthcare Ltd and Serac Imaging Systems Ltd are wholly owned subsidiaries of Serac Life Sciences Ltd.

Quick Links
Registered Office: 6th Floor, Charlotte Building, 17 Gresse Street, London W1T 1QL. Company Number: 11074844. VAT No: 288 9284 31.
Copyright © 2024 by Serac Life Sciences Ltd.
Privacy & Cookie Policy
ESG Policy

Powered by Webtec

Create an account to access this functionality.
Discover the advantages

Create account